시험이 몇 일 남지 않았다, 일개 중간고사 일 뿐. 

하늘이 흐리지만 푸르스름한, 맑은 하루가 예상되는 아침이다. 회사에 공부를한다는 목적으로 따라와 로비에 앉는다. 커피를 주문하니 자이언트 핑크 마카롱 따위를 나누어준다, 발렌타인데이라며. 좋아하지도 않는 마카롱인데 넘나 맛있는 것. 어쩌면 나는 싫다는 이유로 내가 좋아하는 것들을 외면하는지도 모르겠다.

시험이 하나 둘, 이면 이번 학기가 끝난다. 그렇게 봄방학 그리고 마지막 학기가 다가온다. 삼학년을 시작하며 마지막 기회라고 적었던 글이 생각난다. 나는 주어진 기회를 잘 활용하였는가. 내가 무엇을 할 수 있을지에 대한 고민이 든다. 무언가 특별한, 나에게 적합한 공간과 직업이 있을 것이라는 확실함 없는 설레임이라는 불안함이 든다.

rotation sites

화가난다, 누구의 책임도 아닌 랜덤이라는 과정에서 태어난 결과이지만, 어딘가 내가 기회를 놓쳤다는 기분에, 화가난다. 누구의 책임도 아니라는 말이 너무나 무책임타, 내가 보다 빨리 신청서를 내었다면 따위의 자책의 객관적인 생각인지 망상인지 따위가 머리를 복잡케한다. 

work and first annual evaluation

went in without expectations and with healthy nervousness. all good things were said to my relief.

ive mentioned wanting to spend this break focusing more on work as i feel i do not work as much as my colleagues. my manager pointed out comparing self to others is not a comment that she receives often and that she is seeking quality not quantity. that high focus and contribution is noticing everyone is on a different page.

felt somewhat embarassed of my method of reflection. was an opportunity to reevaluate myself objectively.

want to do something 

ESSB 5557 - WSPA Alert: Landmark Provider Status Legislation Signed by Governor Inslee

Monday, May 11, 2015   (0 Comments) 
Posted by: Kathleen Goodner

Landmark Legislation Paves Way for Pharmacists to Improve Patient Care

RENTON, WA (May 11, 2015) – The Washington State Pharmacy Association (WSPA) announced today that Governor Inslee signed into law ESSB 5557. This landmark law, sponsored by Senator Linda Parlette, is the first of its kind in the nation to require health insurance carriers to include pharmacists as network providers. This law will increase patient access to medical care from pharmacists practicing within their scope of practice. We are proud that Washington State pharmacists continue to lead the way in providing innovative, quality care to patients. This bill passed with overwhelming bipartisan support due of the leadership of Sen. Parlette, and Rep. Shelley Short, as well as partnership with the Washington State Medical Association, Washington State Hospital Association, and patient advocacy groups.

Until now, health insurance carriers only recognized pharmacists for dispensing medication. This restriction blocked patients from receiving medical care from pharmacists practicing within their scope of practice.

“Removing these barriers will allow pharmacists to directly care for patients in all practice settings,” said Jeff Rochon, Chief Executive Officer for the Washington State Pharmacy Association. “This common sense solution encourages greater collaboration among health providers and brings health care to patients in our communities.”

ESSB 5557 requires health insurance carriers to recognize pharmacists in the same way as other providers. Pharmacists care for patients by managing their chronic diseases in care teams to improve patient outcomes. Working collaboratively with other providers, pharmacists will effectively be able to provide a broad spectrum of patient care services that prevent patient harm, and reduce emergency department visits and hospital readmissions. This will greatly benefit communities with shortages of primary care physicians.

“We are excited that pharmacists will have opportunities to increase collaboration within the health care team in patient-centered medical homes and Accountable Care Organizations, with the focus being on quality and safety,” added Rochon. “This is a huge development within our healthcare system, and we’re excited that pharmacists will finally be able to utilize all our skills to help patients.”

“The passage of ESSB 5557 simply means that patients will have greater access to high quality care services. Most people only know pharmacists as their trusted prescription partner but now pharmacists will more closely partner with each patient’s medical provider as an exquisitely trained medication specialist,” stated Don Downing, Clinical Professor at the University of Washington School of Pharmacy.

http://www.wsparx.org/news/news.asp?id=230992 

약대생활이라는 무려 글 카테고리를 만들었는데 글을 남길 시간이 없다. 

나의 모든 시간, 에너지, 돈이 학교로 투자된 듯한 한 해. 하지만 관심은 되려 여행, 휴식, 요리로 돌아가는 - 쉽지만은 않은 현실의 그림. 

be careful what you wish for 나는 약대가 너무 가고싶었고 그 꿈을 이루었다. 나는 Swedish 에서 인턴이 너무나 하고싶었고, 1년이 지난 지금에서, 돌아보니 오히려 적절한 이 시점에 그 꿈을 이루었다. 

i remember feeling so uncertain - the fear of the potential being there yet being only a potential. knowing that it is not the end of the world, but yet also knowing how horrible it'd feel to face failure. 

막연히 원하던 것을 이룬 신남은 지난지 오래, 이미 종점을 바라본다, 하루하루가 길다. 가끔 울고 싶은데 원인을 알 수 없을 시, 시험기간이어서 그래라며 의미를 정의콘한다, 늘 항상 시험기간이니까. 방학이고싶다, 주말인데도 방학이고싶고, 여름인데도 여름이고싶다. 과정에 투자가 필요. 

한 학기의 마무리, cadaver. 

다음 학기의 introduction 으로 cadaver lab 에서 한 학기를 마무리. 

모든 과제와 시험을 제출 후에도 성적에 대한 긴장감에 한국에 도착한지 한 주가 지나서 모든 성적들이 공개된 후에야 마음 편히 휴식. 자신에 대한 뿌듯함과 가족 친구들에대한 감사함을 가득 느끼며 모든 것을 내려놓고 3 주의 겨울 방학. 수고한만큼 수고 할 만큼 작정하고 먹고 자고 놀고, 행복. 

충전된 몸과 마음으로 두번째 학기의 시작 day 2. 첫 학기의 연장인 수업들은 익숙하면서도 지난 학기의 내용을 기억해야한다는 부담감. 아주 새로운 수업들은 어색하지만 신선함. 

편안한 명상 교양과목은 새로운 경험. 약대 이외에 의대 치대 간호대생들로 구성된 10명의 학생들의 소통형식 수업. 학교들의 특성상 다들 상당한 목적의식 집중력, 동기와 경험들을 바탕한 학생들. 나의 1. now 2. with biggest problem 3. without biggest problem 의 모습들을 크래용으로 그린 결과를 각자 발표. 나의 세 그림은 신기하게도 모두 비슷. 다만 3번을 그리며 가장 행복했고 palm tree 가득한 푸르른 beach 에 친구들과 휴양하는 모습을 그림. 모든 그림에는 친구들과 가족들이 함께했고 2번에는 나와 친구들과 가족과 나무 몇 그루만 존재. 

나의 그림들보다 신선했던 것은 다른 학생들의 표현. 모두 사회적으로 제법 성취감 느낄만한 위치에 있음에도 불구하고 모두들 상당한 스트레스와 고민들을 안고사는 듯. 여러 학생들이 어떠한 결정을 내려야 할지 모르는 것을 현재의 문제로 표현했고 문제 없는 모습에는 고민하지 않는 자신의 모습을 그림. decision making 이 없는 시간은 없을텐데라는 생각을 가진 나로써는 어딘가 불가능한 이상향이라는 느낌을 받음. 그리고 살면서 당연히 있을 법한 고민들인데 그에 대해 참으로 많은 스트레스를 받는 학생들을 보며 필요 이상의 집착이 아닌지 싶은 인상을 받음. 

반면 나만 너무 속편히 생활하는가, 싶은 생각도 듬. 개인적으로 가장 특이하다거나 이상적이었던 고민들 중에는 주위 사람들의 죽음이나 자살, 이혼. 하지만 이혼 마저도 흔한 사회적 고민이지 않은가. 그 현실은 얼마나 어려울까, 싶음. 반면 나에게 보편적으로 느껴진 고민들 중에는 졸업 후의 진로를 고민하는 학생들도 다수. 이것은 나 또한 가지고있는 고민. 이것이 나의 생활에 가장 큰 요소일만큼 큰 고민은 아니라는 생각이, 나만 가진 생각인지 의문. 

결론적으로 나의 속은 참 편안하구나 싶음. 

이번 학기 학점을 제법 많이 듣는데 괜찮을지 의문. 벌써 이번 주 부터 시험들이 시작, 좋다.

표어	Lux Sit (빛이 있으라)
설립	1861년
종류	주립
총장	마이클 영 (Michael K. Young)
국가	미국
위치	워싱턴주 시애틀
학생 수	학부: 27,868 대학원: 13,081
상징	허스키(Huskies)
웹 사이트	http://www.washington.edu/

워싱턴 대학교(영어: University of Washington,줄여서 UW)는 미국 워싱턴주 시애틀에 있는 주립 대학이다. 캠퍼스의 크기는 약 2.845㎢이며 그 안에 기숙사를 포함한 213개 동의 건물이 있다. 현재 구글, 마이크로소프트, 애플의 본거지인만큼 세계 내 IT계열로 강한 대학으로 손꼽힌다. 특히 시애틀 출신인 빌 게이츠는 지금까지 매년 워싱턴 대학교에 기부 중이다. 워싱턴 대학교는 미국 북서부 지방에서 가장 큰 규모의 대학이며, 미국 서부지방에서는 가장 오래된 대학이기도 하다. 오래되고 이름난 대학인만큼 교정도 고풍스럽고 아름다워 영화 해리 포터 개봉이후 호그와트처럼 웅장하고 눈부시다며 미국의 호그와트라고도 불린다. 보통 줄여서 UW (U-Dub:유덥으로 발음) 이라고 부른다. 시애틀의 번화가(Downtown) 에서 약 5마일 떨어져 있다. 학생들의 학교 만족도는 높으며 다른 주립대학들과 비교했을 때 학비가 비싼 편에 속한다.

메인 캠퍼스인 시애틀 (Seattle) 캠퍼스 외에도 타코마 (Tacoma), 바슬 (Bothell) 캠퍼스가 있다. 페이지에 기재된 워싱턴 대학교의 순위는 시애틀 캠퍼스 기준이다. 2011년, Academic Ranking of World Universities 는 워싱턴 대학교를 세계 16위에 꼽았다.^[1] 임상의학대학원, 약리학 에 대해 세계 3위를 차지하였다.^[2]

2014년 가을에 입학할 신입생의 경우 지원자 58%인 24,540명이 합격했으며 신입생들의 평균 대학수학능력시험SAT 성적은 2400만점에 1883점이었다.^[3]

지금까지 총 12명의 노벨상 수상자, 13명의 퓰리처상 수상자, 1명의 필즈상 수상자를 배출했다.

2014년에 미국내 권위적인 US News & World Report에 의하면 조지워싱턴대학교, 오하이오 주립대, 투레인 대학교, 그리고 텍사스 주립대와 함께 미국내에서 공동으로 52위를 기록하였

다.^[4]

2012년에는 영국 타임스 지가 선정한 세계대학랭킹 중 25위를 차지하였다.^[5]

2012년에는 매년 미국 국내 대학 순위를 발표하는 시사 주간지 US News & World Report에서 의과대학원의 일차진료(Primary Care) 관련하여 미국내 1위를 차지하였다.^[6]

^wiki

University of Washington 

School of Pharmacy 

Mission & Vision

Foundation and Values

The School of Pharmacy is an inclusive community that fosters an environment supportive of advancing our goals and enabling us to take active roles in regional and global initiatives relating to our overall mission. We are committed to a culture that is open, ethical, and collaborative, embraces excellence, respects diversity of thought, and encourages diversity among its faculty, staff and students.

School Vision

To be recognized nationally and internationally as a leader in pharmacy education, research and service that partners effectively with others to promote the discovery, development and appropriate use of medications for the welfare and safety of the public.

Mission Statement

Instructional: We educate student pharmacists to work in partnership with other health professionals to provide accessible, compassionate, and integrative pharmaceutical care with the goal of enhancing patient outcomes. In addition, we provide high quality graduate and post-graduate education tailored to foundational and advanced training in the pharmaceutical, clinical and health outcomes sciences.

Research and Discovery: We provide scientific leadership through development of innovative research programs in the biomedical sciences, conduct basic, translational and outcomes research, and make informed decisions at preclinical, clinical and post-approval stages of drug discovery, development and implementation.

Service: We serve patients and the wider community as committed and compassionate leaders in the use of our knowledge and discoveries to help develop and disseminate solutions to complex healthcare problems and promote the health and well-being of regional, national and global populations.

Educational Philosophy Statement

The goal of the PharmD program is to ensure our graduates possess the knowledge, skills, and abilities necessary to render care in an evolving health care system. Our educational experiences are designed to provide a strong foundation in the biomedical, socio-behavioral, administrative, clinical, and pharmaceutical sciences, a heightened understanding of the economic, cultural and social issues affecting patients and health care delivery, and the ability to apply this knowledge in collaboration with others to further practice, education, and research. Students are also encouraged, through professional and community outreach activities, to develop and incorporate new practices that enhance public health, systems management, and patient-centered care in diverse populations and settings. 

Strategic Plan

The School of Pharmacy 2010 Strategic Plan addresses the instructional, research and service missions of the School. Because these missions are highly interrelated, there is a unifying focus of the strategic plan: to promote “the safe, rational and cost-effective use of pharmaceuticals in patients and populations.” Read the Strategic Plan (PDF).

FACTS & HIGHLIGHTS 2013

At the University of Washington School of Pharmacy, we are committed to educating the next generation of leaders in pharmacy, pharmaceutical research and health care — while seeking to ensure the safe, rational and cost-effective use of medicines. View a PDF of our Facts and Highlights.

MISSION STATEMENT

• Instructional: We educate student pharmacists to work in partnership with other health professionals to provide accessible, compassionate, and integrative pharmaceutical care with the goal of enhancing patient outcomes. In addition, we provide high quality graduate and post-graduate education tailored to foundational and advanced training in the pharmaceutical, clinical and health outcomes sciences.
• Research and Discovery: We provide scientific leadership through development of innovative research programs in the biomedical sciences, conduct basic, translational and outcomes research, and make informed decisions at preclinical, clinical and post-approval stages of drug discovery, development and implementation.
• Service: We serve patients and the wider community as committed and compassionate leaders in the use of our knowledge and discoveries to help develop and disseminate solutions to complex healthcare problems and promote the health and well-being of regional, national and global populations.

OUR DEAN: Thomas A. Baillie, PhD, DSc

OUR STUDENTS

PharmD Students: 381
PhD Students: 59 
MS Students: 40

PharmD Student Demographics & Statistics:

American Indian/Native Alaskan: 1%
Asian, Pacific Islander & Hawaiian: 53%
Black 1%
Hispanic 3%
White 36%
Other: 4%
***
Female: 64%
Male: 36%
***
The North American Pharmacist Licensure Examination (NAPLEX) pass rate for 2013 PharmD graduates who took the exam in 2013 was 100%. 
The Multistate Pharmacy Jurisprudence Examination (MPJE) pass rate for 2013 was 93.55%. 
The on-time graduation rate for the Class of 2013 was 88%. 
More than 34 percent of PharmD graduates from the class of 2014 have been selected for PGY1 residencies, fellowships or other postgraduate opportunities.

DEPARTMENTS & PROGRAMS

Under the leadership of Dean Thomas A. Baillie, PhD, DSc, the School of Pharmacy has 42 full-time equivalent faculty members. The following departments and programs are each centers of excellence in their own right: 

Department of Medicinal Chemistry
Conducting research in drug metabolism, bio-analytical chemistry and the biophysical characterization of viral protein assembly
Chair: Allan E. Rettie, PhD 

Department of Pharmaceutics
Conducting research in pharmacokinetics and drug disposition
Chair: Kenneth E. Thummel, PhD 

Department of Pharmacy
Leading in pharmacy education, research, and professional and outreach initiatives
Chair: Peggy S. Odegard, PharmD 

Pharmaceutical Outcomes Research & Policy Program
Conducting research in pharmaceutical economics, drug safety and pharmaceutical policy
Director: Sean D. Sullivan, PhD

RANKINGS

• We are the No. 10 ranked pharmacy school in the nation, according to U.S. News & World Report.  
• Faculty secured more than $14 million in overall research funding in fiscal year 2013.
• In fiscal year 2012, we received $9.1 million in National Institutes of Health grant funding.

EDUCATIONAL OFFERINGS

Professional Degree: Doctor of Pharmacy (PharmD) 
Master of Science (MS): Medicinal Chemistry, Pharmaceutical Outcomes Research & Policy Program (PORPP), Pharmaceutics, Professional MS in Biomedical Regulatory Affairs 
Doctor of Philosophy (PhD): Medicinal Chemistry, Pharmaceutics, PORPP 
Concurrent Degrees: PharmD/Physician Assistant, PharmD/MS, PharmD/PhD 
Certificate Programs: Biomedical Regulatory Affairs, Clinical Trials, Comparative Effectiveness Research, Health Economics and Outcomes Research, Plein Certificate in Geriatric Pharmacy 
Residency Programs: Ambulatory Care, Community Pharmacy, Critical Care, General Residency, Oncology, Pharmacy Management/Master of Health Administration

AWARDS & HONORS

• Faculty hold leadership roles in associations including the American Association of Colleges of Pharmacy, American Association of Pharmaceutical Scientists (AAPS), American Chemical Society, American Society for Pharmacology and Experimental Therapeutics (ASPET), International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for the Study of Xenobiotics.
• Recent faculty honors include an AAPS Research Achievement in Biotechnology Award, an AAPS Research Achievement in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism Award, an Early Career Achievement Award from ASPET, and an American Society for Parenteral and Enteral Nutrition Distinguished Nutrition Support Pharmacist Service Award.
• Recent student honors include two UW Thomas Francis, Jr., Global Health Fellowships, an ISPOR Distinguished Service Award, and a Chapter Achievement Award for our student chapter of the American Pharmacists Association-Academy of Student Pharmacists.

RESOURCES & RESEARCH CENTERS

• Analytical Biopharmacy Core
• Bracken Pharmacy Learning Center
• DNA Sequencing and Gene Analysis Center
• Mass Spectrometry Center
• Metabolism and Transport Drug Interaction Database
• Northwest-Alaska Pharmacogenomics Research Network
• Pharmacokinetics Lab
• UW Obstetric-Fetal Pharmacology Research Unit
• UW Pharmacy Cares Consulting Pharmacy
• UW Research Affiliates Program on Transporters

FISCAL YEAR 2013 REVENUE: $34 MILLION

FUN FACTS

• The School (then College) of Pharmacy was founded in 1894 as the third college at the UW.
• Louis D. Bracken, the inventor of the original “Blistex” lip ointment, attended the College of Pharmacy in 1912 and 1913.
• Bill Stavropoulos, PhD in Medicinal Chemistry, ’67, served as president, COO and chairman of Dow Chemical Company.
• George Bartell, Jr., ’53, was the president and CEO of Bartell Drugs for 44 years. Bartell was the son of the founder of the family-owned drug store chain, which is the nation’s oldest.
• Impel NeuroPharma, a company seeking to enable drugs to bypass the blood-brain barrier, was co-founded in 2008 by Professor of Pharmaceutics Rodney Ho and John Hoekman, PhD, ’10.
• UW Pharmacy Cares, founded at the School of Pharmacy in 2008, was the first ever non-dispensing, medication-therapy-management-focused pharmacy licensed in the state of Washington.

 

University of Washington School of Pharmacy's Doctor of Pharmacy programis accredited by the Accreditation Council for Pharmacy Education, 135 South LaSalle Street, Suite 4100, Chicago, IL 60503, 312-664-3575, FAX 312-664-4652,www.acpe-accredit.org.

 http://sop.washington.edu/school-of-pharmacy/